These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 807769)

  • 1. 32P-therapy in polycythemia vera.
    Meuret G; Hoffmann G; Gmelin R
    Klin Wochenschr; 1975 Jun; 53(11):519-21. PubMed ID: 807769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of polycythemia vera: use of 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age. The French Polycythemia Study Group.
    Najean Y; Rain JD
    Blood; 1997 Apr; 89(7):2319-27. PubMed ID: 9116275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with radioactive phosphorus therapy in cases of polycythemia vera (author's transl)].
    Meuret G; Hoffmann G; Gmelin R
    Strahlentherapie; 1975 Jan; 149(1):49-54. PubMed ID: 1124554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations on polycythemia vera turning into acute or chronic granulocytic leukemia during treatment with radioactive phosphorus 32P.
    Krańik W
    Pol Med Sci Hist Bull (1973); 1975; 15(4):447-52. PubMed ID: 1063385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Remission incidence and adverse effects in low-dosage radioactive phosphorus therapy of polycythemia vera].
    Hauswaldt C; Horejschi J; Emrich D; Heckner F; Douwes FW; Ziesemer G
    Verh Dtsch Ges Inn Med; 1975; 81():1128-30. PubMed ID: 1229414
    [No Abstract]   [Full Text] [Related]  

  • 6. Maintenance therapy of 32P-induced remission in polycythemia vera. A clinical trial of chlorambucil and hydroxy-urea in 109 cases.
    Najean Y; Dresch C; Rain JD
    Nouv Rev Fr Hematol (1978); 1978 Nov; 20(3):377-85. PubMed ID: 112580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of the myeloproliferative disorders with 32P.
    Berlin NI
    Eur J Haematol; 2000 Jul; 65(1):1-7. PubMed ID: 10914933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present status of 32P-therapy in management of polycythemia vera.
    Meuret G
    Klin Wochenschr; 1975 Jun; 53(12):555-8. PubMed ID: 1195656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of 32 phosphorus (32P) in the treatment of polycythemia vera.
    Parmentier C; Gardet P
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):189-92. PubMed ID: 8036140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiophosphorus therapy of polycythemia vera].
    Hör G; Pabst HW
    Ther Umsch; 1973 Nov; 30(11):789-96. PubMed ID: 4591693
    [No Abstract]   [Full Text] [Related]  

  • 11. [Radioactive phosphorus (32P); an old, but not bad treatment in polycythemia vera].
    Michiels JJ; van Genderen PJ
    Ned Tijdschr Geneeskd; 1997 Jan; 141(3):168-9. PubMed ID: 9053768
    [No Abstract]   [Full Text] [Related]  

  • 12. Busulfan versus 32P in polycythaemia vera.
    Zittoun R
    Drugs Exp Clin Res; 1986; 12(1-3):283-5. PubMed ID: 3525077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".
    Najean Y; Rain JD; Dresch C; Goguel A; Lejeune F; Echard M; Grange MJ
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():111-9. PubMed ID: 8951781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute leukemia and primary Vaquez' polycythemia. 20 cases].
    Bernard JF; Renoux M; Dhermy D; Schneider M; Chouraqui F; Amar M; Boivin P
    Sem Hop; 1978 Sep 18-25; 54(25-28):797-804. PubMed ID: 214857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of different doses of 32P in the treatment of primary thrombocytosis.
    Randi ML; Fabris F; Varotto L; Peverelli P; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):950-6. PubMed ID: 2419226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polycythemia vera and its treatment with radioactive phosphorus (32P)].
    Antić M
    Vojnosanit Pregl; 1984; 41(6):451-63. PubMed ID: 6523775
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.
    Berk PD; Goldberg JD; Silverstein MN; Weinfeld A; Donovan PB; Ellis JT; Landaw SA; Laszlo J; Najean Y; Pisciotta AV; Wasserman LR
    N Engl J Med; 1981 Feb; 304(8):441-7. PubMed ID: 7005681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacious treatment of a fatal blood disease: polycythemia vera].
    Sánchez Fayos J; Román Barbero A; Nevado Reviriego I
    Sangre (Barc); 1997 Jun; 42(3):215-8. PubMed ID: 9381264
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of polycythemia with 32P].
    Vlakhov N; Parusheva D; Kostov K
    Med Radiol (Mosk); 1986 Mar; 31(3):55. PubMed ID: 3959801
    [No Abstract]   [Full Text] [Related]  

  • 20. Haematological complications in polycythaemia vera and thrombocythaemia patients treated with radiophosphorus (32P).
    Randi ML; Fabris F; Varotto L; Rossi C; Macri C; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):461-7. PubMed ID: 1703118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.